Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (unaudited)

Condensed Statement of Cash Flows (unaudited)
3 Months Ended
Dec. 31, 2017
USD ($)
Operating Activities  
Net loss $ (145,928)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (47,784)
Change in operating assets and liabilities:  
Prepaid expenses (152,417)
Accounts payable 3,009
Other current liabilities 83,227
Net cash used in operating activities (259,893)
Investing Activities  
Restricted cash (71,640)
Investment of cash in Trust Account (125,000,000)
Net cash used in investing activities (125,071,640)
Financing Activities  
Proceeds from sale of Units, net of underwriting discounts paid 122,500,000
Proceeds from sale of Private Placement Units 4,895,000
Proceeds from the sale of Founder Shares 25,000
Promissory notes from related parties 50,536
Repayment of promissory notes from related parties (50,536)
Payment of deferred offering costs (380,205)
Net cash provided by financing activities 127,039,795
Net change in cash and cash equivalents 1,708,262
Cash and cash equivalents, end of period $ 1,708,262